other material
confidence high
sentiment positive
materiality 0.60
ASP Isotopes unit QLE signs binding HALEU joint-venture agreement with South Africa's Necsa
ASP Isotopes Inc.
- QLE will hold approximately 80% of the Joint Venture and lead operations and capital raising; Necsa holds approximately 20%, contributing site access, safeguards and licensing support.
- The Joint Venture will develop, finance, construct, commission and operate a test bench and commercial-scale HALEU production facility at Necsa's Pelindaba site in South Africa.
- Offtake for the expected HALEU output is already secured through supply agreements with TerraPower, described as a leading advanced nuclear reactor developer.
- Prior milestones: MOU in November 2024, Pre-Implementation Services Contract in February 2026, and July 2026 approval from South Africa's Ministry of Electricity and Energy.
- Necsa's Pelindaba headquarters hosts the 20MW SAFARI-1 research reactor; the parties intend an EPC arrangement giving the project access to Necsa's engineering capabilities.